Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian W Flinn

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Blood|July 21, 2018
PI3K inhibitors and the search for the Holy GrailIan W Flinn
Clinical Advances in Hematology & Oncology : H&O|April 11, 2023
Is there still a role for PI3K inhibitors in CLL?Ian W Flinn
Blood|October 15, 2011
CD37: the comeback kidIan W Flinn
Current Opinion in Oncology|August 23, 2002
Lymphoma therapy: the challenges aheadIan W Flinn
Clinical Advances in Hematology & Oncology : H&O|January 13, 2012
B-cell receptor inhibitors in chronic lymphocytic leukemiaIan W Flinn
Current Opinion in Oncology|December 20, 2002
Chronic lymphocytic leukemia: advances in biology and therapeuticsIvan Aksentijevich, Ian W Flinn
Cancer Control : Journal of the Moffitt Cancer Center|May 15, 2002
Monoclonal antibody therapy with autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaIvan Aksentijevich, Ian W Flinn
Expert Review of Hematology|December 13, 2016
Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same diseaseMichael T Tees, Ian W Flinn
Cancer Treatment and Research|May 18, 2006
Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphomaIan W Flinn, Jesus G Berdeja
Seminars in Oncology|August 27, 2003
Incorporating monoclonal antibodies in blood and marrow transplantationSami N Malek, Ian W Flinn
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Blood|July 21, 2018
PI3K inhibitors and the search for the Holy GrailIan W Flinn
Clinical Advances in Hematology & Oncology : H&O|April 11, 2023
Is there still a role for PI3K inhibitors in CLL?Ian W Flinn
Blood|October 15, 2011
CD37: the comeback kidIan W Flinn
Current Opinion in Oncology|August 23, 2002
Lymphoma therapy: the challenges aheadIan W Flinn
Clinical Advances in Hematology & Oncology : H&O|January 13, 2012
B-cell receptor inhibitors in chronic lymphocytic leukemiaIan W Flinn
Current Opinion in Oncology|December 20, 2002
Chronic lymphocytic leukemia: advances in biology and therapeuticsIvan Aksentijevich, Ian W Flinn
Cancer Control : Journal of the Moffitt Cancer Center|May 15, 2002
Monoclonal antibody therapy with autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaIvan Aksentijevich, Ian W Flinn
Expert Review of Hematology|December 13, 2016
Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same diseaseMichael T Tees, Ian W Flinn
Cancer Treatment and Research|May 18, 2006
Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphomaIan W Flinn, Jesus G Berdeja
Seminars in Oncology|August 27, 2003
Incorporating monoclonal antibodies in blood and marrow transplantationSami N Malek, Ian W Flinn
Pageof 18